Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels of hope. Researchers say it could one day make routine screening far more effective by catching cancers earlier, when treatment has the best chance of saving lives.
The Galleri blood test, developed by US firm Grail, is the latest entrant to attract worldwide attention, after early trial results were described as “exciting” by researchers.
